Genetic interferonopathies: An overview

Interferonopathies comprise an expanding group of monogenic diseases characterised by disturbance of the homeostatic control of interferon (IFN)-mediated immune responses. Although differing in the degree of phenotypic expression and severity, the clinical presentation of these diseases shows a cons...

Full description

Saved in:
Bibliographic Details
Published in:Best practice & research. Clinical rheumatology 2017-08, Vol.31 (4), p.441-459
Main Authors: Eleftheriou, Despina, Brogan, Paul A.
Format: Article
Language:English
Subjects:
Aicardi-Goutières syndrome
CANDLE
Interferonopathies
Proteasome
SAVI
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Interferonopathies comprise an expanding group of monogenic diseases characterised by disturbance of the homeostatic control of interferon (IFN)-mediated immune responses. Although differing in the degree of phenotypic expression and severity, the clinical presentation of these diseases shows a considerable degree of overlap, reflecting their common pathogenetic mechanisms. Increased understanding of the molecular basis of these Mendelian disorders has led to the identification of targeted therapies for these diseases, which could also be of potential relevance for non-genetic IFN-mediated diseases such as systemic lupus erythematosus and juvenile dermatomyositis. In this paper, we summarise the current knowledge of the molecular basis, clinical features and the treatment available for monogenic interferonopathies.
ISSN:1521-6942
1532-1770
DOI:10.1016/j.berh.2017.12.002